These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 3258784)

  • 1. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Chang GD; Ramirez VD
    Brain Res; 1986 Mar; 368(1):134-40. PubMed ID: 3485463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Chang GD; Ramirez VD
    Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN; Sobotka TJ; Weise VK; Markey SP
    J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
    Ozaki N; Nakahara D; Kaneda N; Kiuchi K; Okada T; Kasahara Y; Nagatsu T
    J Neural Transm; 1987; 70(3-4):241-50. PubMed ID: 3500274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies on the dopamine re-uptake mechanism in the striatum of the rat: effects of benztropine, sodium and ouabain.
    Sirinathsinghji DJ; Heavens RP; Sikdar SK
    Brain Res; 1988 Jan; 438(1-2):399-403. PubMed ID: 3345448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
    Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
    Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
    J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
    J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal and urinary DOPAC/DA ratio may indicate a long-lasting DA release enhancement by MPP+ and MPTP.
    Bagchi SP
    Neurochem Res; 1998 Feb; 23(2):127-34. PubMed ID: 9475505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
    Rollema H; De Vries JB; Westerink BH; Van Putten FM; Horn AS
    Eur J Pharmacol; 1986 Dec; 132(1):65-9. PubMed ID: 3102260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Caliguri EJ; Johannessen JN
    Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
    Irwin I; Langston JW; DeLanney LE
    Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
    Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Miele M; De Natale G; Miele E
    Neurosci Lett; 1993 Oct; 161(2):121-3. PubMed ID: 7903798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
    Kass GE; Wright JM; Nicotera P; Orrenius S
    Arch Biochem Biophys; 1988 Feb; 260(2):789-97. PubMed ID: 2963592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.